Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Leroyer

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Haematologica|January 5, 2019
Six months <i>versus</i> two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trialFrancis Couturaud, Gilles Pernod, Emilie Presles, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2022
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studiesAlexandre Fauché, Emilie Presles, Olivier Sanchez, et al.
The European Respiratory Journal|January 6, 2018
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trialCécile Tromeur, Olivier Sanchez, Emilie Presles, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2026
Epidemiology of Venous Thromboembolism during Pregnancy and Postpartum: Results from the French Prospective Multicentre HEMOTHEPP studyEloïse Laouenan, François Anouilh, Emmanuelle Courtois-Communier, et al.
Lancet (London, England)|March 1, 2025
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trialFrancis Couturaud, Jeannot Schmidt, Olivier Sanchez, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Haematologica|January 5, 2019
Six months <i>versus</i> two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trialFrancis Couturaud, Gilles Pernod, Emilie Presles, et al.
Journal of Thrombosis and Haemostasis : JTH|August 26, 2022
Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: Results from PADIS studiesAlexandre Fauché, Emilie Presles, Olivier Sanchez, et al.
The European Respiratory Journal|January 6, 2018
Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trialCécile Tromeur, Olivier Sanchez, Emilie Presles, et al.
Journal of Thrombosis and Haemostasis : JTH|January 30, 2026
Epidemiology of Venous Thromboembolism during Pregnancy and Postpartum: Results from the French Prospective Multicentre HEMOTHEPP studyEloïse Laouenan, François Anouilh, Emmanuelle Courtois-Communier, et al.
Lancet (London, England)|March 1, 2025
Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trialFrancis Couturaud, Jeannot Schmidt, Olivier Sanchez, et al.
Pageof 8